semaglutide and alzheimer's disease Weight Loss Drug Shows Promise as Treatment : ScienceAlert Alzheimer's disease: Semaglutide use linked

doi: 10.1002/jcb.30247, 141

The drug is currently marketed under three brand names: Ozempic and Rybelsus (prescribed for Type 2 diabetes) and Wegovy (prescribed for weight management)

Many users notice an appetite reduction soon after starting the medication and may see modest weight loss after just a few weeks

Individual red and green channels of RBG images from the main figures are shown in Supplementary Fig

SOD: Investigation, Writing review & editing

249,306,341-343 Several meta-analyses (of predominantly cohort studies) have shown that metabolic bariatric surgery confers significant improvement in cardiovascular risk factors including blood pressure, glycaemia, lipids and waist circumference, compared with medical management